Impotence drugs make chemotherapy more effective in rats
WEDNESDAY 30 JULY 2008
A US study has found that drugs used to treat impotence appear to help improve the effectiveness of chemotherapy in rats with brain tumours.
Researchers at Cedars-Sinai Medical Centre found that 'phosphodiesterase5 (PDE5) inhibitor' drugs like Viagra (sildenafil) and Levitra (vardenafil), which increase bloodflow to the penis in people with erectile dysfunction (ED), can also increase the flow of blood - and chemotherapy drugs - across the blood-brain barrier of laboratory rats.
This barrier limits the ability of substances like drugs from moving from the bloodstream into the brain - and therefore limits the effectiveness of chemotherapy.
Study author and neurosurgeon Dr Keith Black, chairman of the Department of Neurosurgery at Cedars-Sinai Medical Centre, commented: "This is the first study to show that oral administration of PDE5 inhibitors increases the rate of transport of compounds across the blood-brain tumour barrier and improves the effectiveness of the anti-tumour drug adriamycin in the treatment of brain tumours in a rat model."
The researchers investigated the impact of the ED drug vardenafil (Levitra) in 29 rats with brain tumours and have now published their findings in the journal Brain Research.
They found that rats treated with the anti-cancer drug adriamycin alone survived for an average of 42 days.
However, animals which also received the ED drug vardenafil survived for an average of 53 days, indicating that the additional drug helped to improve the delivery of the anti-cancer drug to the tumour.
Dr Black concluded: "The combination of vardenafil and adriamycin resulted in longer survival and smaller tumour size."
Number of Britons diagnosed with alcohol-related cancers exceeds Wimbledon's Centre Court
Benefits of international tobacco smuggling protocol would outweigh costs
Women and GPs lack awareness of ovarian cancer symptoms
One in 25 deaths attributable to alcohol
Patients with suspected cancer to see specialist within two weeks
Animal fats linked to pancreatic cancer
Promising experimental drug targets cancer 'Achilles heel'
Cervical cancer screening age to stay at 25
NICE approves lenalidomide for multiple myeloma patients who have received previous treatments
Scientists identify inhibitor of tumour spread
